Results 91 to 100 of about 605 (133)

Effectiveness and safety of rivaroxaban vs warfarin in patients with pulmonary embolism and right ventricular dysfunction: a retrospective cohort study. [PDF]

Res Pract Thromb Haemost
Laliberté F, Bikdeli B, Ashton V, Germain G, Boudreau J, Sundar M, MacKnight SD, Bookhart B, Wentworth D, Murphy S, Hsieh YG, Piazza G.   +11 more
europepmc   +1 more source

Advances in occult cancer screening for patients with unprovoked venous thromboembolism: A narrative review of epidemiology, risk, and clinical strategies. [PDF]

J Vasc Surg Venous Lymphat Disord
Wen J, Zhang C, Wu F, Zeng Q.
europepmc   +1 more source

Genome-Wide Search for Nonadditive Allele Effects Identifies <i>PSKH2</i> as Involved in the Variability of Factor V Activity. [PDF]

J Am Heart Assoc
Gendre B, Martinez-Perez A, Kleber ME, van Hylckama Vlieg A, Boland A, Olaso R, Germain M, Munsch G, Moissl AP, Suchon P, Souto JC, Soria JM, Deleuze JF, März W, Rosendaal FR, Sabater-Lleal M, Morange PE, Trégouët DA, CHARGE Hemostasis Working Group.   +18 more
europepmc   +1 more source

Management of an inferior vena cava thrombus with comorbid intracranial haemorrhage and cerebral amyloid angiopathy. [PDF]

BMJ Case Rep
MacKay K, Dinh CA, Dugani SB.
europepmc   +1 more source

[Prevention of thromboembolic disease in patients with heart disease]. [PDF]

Aten Primaria, 2000
Galindo G, Peiró R, Plana A, Navarro MA, Berdié J, Morató J.   +5 more
europepmc   +1 more source

Real-World Assessment of All-Cause Hospital Readmissions among Pulmonary Embolism Patients Treated With Rivaroxaban Versus Apixaban. [PDF]

Clin Appl Thromb Hemost
Ashton V, Germain G, Boudreau J, Sundar M, MacKnight SD, Murphy S, Hsieh YG, Laliberté F.   +7 more
europepmc   +1 more source

Low-Density Lipoprotein Cholesterol Levels and Bleeding Risk in Venous Thromboembolism.

JAMA Netw Open
Siniscalchi C, Meschi T, Di Micco P, Imbalzano E, Hernández-Blasco L, Mahé I, Fernández-Reyes JL, García-Ortega A, Verhamme P, Alfonso-Megido J, Monreal M, RIETE Investigators.   +11 more
europepmc   +1 more source

Assessment of bleeding events in patients receiving DOACs with or without statins to treat venous thromboembolism: insights from the RIETE registry. [PDF]

BMJ Open
Del Giorno R, Mazzolai L, Keller S, Siniscalchi C, Lopez-Jimenez L, Ballaz A, Montenegro AC, Otero R, Rashidi F, Monreal M, RIETE Investigators.   +10 more
europepmc   +1 more source

[Increased risk of bleeding in patients with atrial fibrillation and chronic kidney disease on hemodialysis treated with anticoagulants. A four center serie]. [PDF]

Arch Cardiol Mex
López-Gutiérrez LV, Mora-Atehortúa MI, Peláez-García S, Jaimes-Barragán FA, Saavedra-González YA, Ossa-Estrada DA, Villegas-Molina JP, Polo-Guzmán AH, Saldarriaga-Giraldo CI.   +8 more
europepmc   +1 more source

Evaluating the Safety of Combining Tyrosine Kinase Inhibitors with Anticoagulants in Chronic Myeloid Leukemia: A Systematic Review.

Oncology
Gameil A, Ghasoub R, Jafari N, Shafei L, Benkhadra M, Laws S, Hamad A, Sabet I, Milojkovic D, Fernyhough L.   +9 more
europepmc   +1 more source